Bioaraba
Centro de investigación
IQVIA
Madrid, EspañaPublicaciones en colaboración con investigadores/as de IQVIA (4)
2023
-
Extrapyramidal adverse events and anticholinergics use after the long-term treatment of patients with schizophrenia with the new long-acting antipsychotic Risperidone ISM®: results from matching-adjusted indirect comparisons versus once-monthly formulations of Paliperidone palmitate and Aripiprazole monohydrate in 52-week studies
Annals of General Psychiatry, Vol. 22, Núm. 1
2011
-
Development and validation of the SEC-QOL questionnaire in women using contraceptive methods
Value in Health, Vol. 14, Núm. 6, pp. 892-899
2007
-
Treatment of chronic he1patitis C genotype 1 with peginterferon- α2a (40 kDa) plus ribavirin under routine clinical practice in Spain: Early prediction of sustained virological response rate
Alimentary Pharmacology and Therapeutics, Vol. 25, Núm. 8, pp. 899-906
2006
-
Desarrollo y validación de un cuestionario de satisfacción con el tratamiento en pacientes con artritis reumatoide
Reumatologia Clinica, Vol. 2, Núm. 3, pp. 137-145